Sedation: Clinical Trials

20 trials for Sedation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 3 unknown, 3 withdrawn, 1 not yet recruiting. 20 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 120Completed 12, Unknown 3, Withdrawn 3, Not yet recruiting 1, Terminated 1
Phase 23Completed 1, Not yet recruiting 1, Unknown 1

Follow Sedation: new trials by email Literature Review of Sedation trials Research Report on Sedation

Trials (filtered) newest first · largest first

All 20 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Children of Age 2-6years Undergoing Elective Surgery Will be Divided Into Two Groups Randomly. This Study Aims to Evaluate if Intranasal Dexmedetomidine is Better Than Intranasal Ketamine in Producing Sedation and Reducing Parent Separation Anxiety Before Surgery.
Intranasal dexmedetomidine, Intranasal ketamine - Sedation, Preoperative Anxiety Experienced by the Pediatric Patient
Phase 1 / Phase 2Not yet recruitingLiaquat National Hospital & Medical College602026-01-012025-09-18
The Dreamy Jet Study
Ketamine - Sedation, Blood Drawing Procedure
Phase 1WithdrawnUniversity of Wisconsin, Madison2025-09-012025-08-12
Lidocaine Infusion for Propofol Dose Reduction in ERCP Procedure
Placebo, Lidocaine - Sedation
Phase 1UnknownIuliu Hatieganu University of Medicine and Pharmacy1002022-01-032022-03-11
Pre-emptive Pregabalin on Attenuating Maternal Anxiety And Stress Response To Intubation During Caesarean Section
Pregabalin 150mg, multivitamin - Anxiety State, Sedation
Phase 1 / Phase 2UnknownZagazig University742020-11-152021-02-04
A Study Evaluating the Mass Balance of Micro-dose[14C]HSK3486 Emulsion Injection in Healthy Adults
HSK3486 - Anesthesia, Sedation
Phase 1WithdrawnSichuan Haisco Pharmaceutical Group Co., Ltd2020-03-302022-06-02
A Study Evaluating Drug-Drug Interaction (DDI) Between HSK3486 Injectable Emulsion and Voriconazole Tablets
HSK3486, voriconazole +HSK3486 - Anesthesia, Sedation
Phase 1CompletedSichuan Haisco Pharmaceutical Group Co., Ltd162019-12-142020-12-19
A Study Evaluating the Safety and Pharmacokinetics/Pharmacodynamics of HSK3486
HSK3486, Propofol - Anesthesia, Sedation
Phase 1CompletedSichuan Haisco Pharmaceutical Group Co., Ltd162019-01-092020-01-09
A Study Evaluating the Mass Balance of [14C]HSK3486 Emulsion Injection in Healthy Adults.
HSK3486 - Anesthesia, Sedation
Phase 1CompletedSichuan Haisco Pharmaceutical Group Co., Ltd62019-01-062019-10-28
A Study Evaluating Drug-Drug Interaction (DDI) Between HSK3486 Injectable Emulsion and Rifampin Capsules
HSK3486, rifampin , HSK3486 - Anesthesia, Sedation
Phase 1CompletedSichuan Haisco Pharmaceutical Group Co., Ltd162018-12-142019-08-20
Safety, Pharmacokinetics and Pharmacodynamics of Intranasal Dexmedetomidine in Healthy Subjects
Intranasal Dexmedetomidine, Intravenous Dexmedetomidine, Intranasal Placebo - Sedation
Phase 1UnknownJiangsu HengRui Medicine Co., Ltd.482017-07-262018-01-23
A Study Evaluating Safety, Pharmacodynamics and Pharmacokinetics of HSK3486 and Etomidate for Induction of Anesthesia in Healthy Male Subjects
HSK3486+ etomidate - General Anesthetic, Sedation
Phase 1CompletedSichuan Haisco Pharmaceutical Group Co., Ltd252016-11-302019-08-13
A Study Evaluating Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Single IV Dose of HSK3486 Injectable Emulsion in Healthy Subjects.
HSK3486 - Anesthesia, Sedation
Phase 1CompletedSichuan Haisco Pharmaceutical Group Co., Ltd242016-05-012020-03-03
A Study Evaluating Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of HSK3486 Single Bolus Dose Followed With a 30 Minute Constant Infusion in Healthy Male Subjects
HSK3486 - Anesthesia, Sedation
Phase 1CompletedSichuan Haisco Pharmaceutical Group Co., Ltd132015-11-102021-01-29
Evaluating the Safety, Pharmacodynamics and Pharmacokinetics of HSK3486 in Healthy Female Subjects.
HSK3486, Propofol - Anesthesia, Sedation
Phase 1CompletedSichuan Haisco Pharmaceutical Group Co., Ltd252015-04-222019-07-31
A Study Evaluating the Safety, Pharmacodynamics and Pharmacokinetics of HSK3486 in Healthy Subjects.
HSK3486, Propofol, Placebo - Anesthesia, Sedation
Phase 1CompletedSichuan Haisco Pharmaceutical Group Co., Ltd482014-04-132019-07-26
Phase I, Single Centre, Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD3043
AZD3043 - Safety, Tolerability
Phase 1WithdrawnAstraZeneca2010-03-012012-12-20
Bioavailability of Dexmedetomidine After Intranasal Administration
Intravenous dexmedetomidine, Intranasal dexmedetomidine - Sedation
Phase 1CompletedUniversity of Turku72009-03-012010-01-13
Pharmacokinetics of Dexmedetomidine During Prolonged Infusion in ICU
Dexmedetomidine - Pharmacokinetics, Sedation
Phase 1CompletedOrion Corporation, Orion Pharma132008-09-012009-04-21
Pharmacokinetics of Low Dose Ketamine Infusion
Ketamine - Sedation, Opioid Tolerance
Phase 1TerminatedUniversity of Texas Southwestern Medical Center52006-06-012016-10-26
Clonidine-Remifentanil. Effect of the Combination on Acute Pain and Respiration in Healthy Volunteers
Remifentanil+clonidine - Acute Pain, Respiration
Phase 1 / Phase 2CompletedOslo University Hospital122005-02-012011-07-06

Narrower conditions

Acute Pain (1)  ·  Agnosia (1)  ·  Anxiety Disorders (1)  ·  Respiratory Aspiration (1)

Broader conditions

Neurologic Manifestations (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Mental Disorders (1)  ·  Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)  ·  Pain (1)  ·  Pathologic Processes (1)  ·  Perceptual Disorders (1)  ·  Respiration Disorders (1)  ·  Respiratory Tract Diseases (1)

Interventions

HSK3486 (9)  ·  Propofol (3)  ·  Ketamine (2)  ·  AZD-3043 (1)  ·  Clonidine (1)  ·  Dexmedetomidine (1)  ·  Geritol (1)  ·  Lidocaine (1)  ·  Pregabalin (1)  ·  Remifentanil (1)  ·  Rifampin (1)

Sponsors

Sichuan Haisco Pharmaceutical Group Co., Ltd (10)  ·  AstraZeneca (1)  ·  Iuliu Hatieganu University of Medicine and Pharmacy (1)  ·  Jiangsu HengRui Medicine Co., Ltd. (1)  ·  Liaquat National Hospital & Medical College (1)  ·  Orion Corporation, Orion Pharma (1)  ·  Oslo University Hospital (1)  ·  University of Texas Southwestern Medical Center (1)  ·  University of Turku (1)  ·  University of Wisconsin, Madison (1)  ·  Zagazig University (1)

Countries

China (5)  ·  Finland (2)  ·  United States (2)  ·  Egypt (1)  ·  Norway (1)  ·  Romania (1)

Top investigators

Brendan Smyth (1)  ·  Cindy Darnell, MD (1)  ·  Daniela Ionescu, MD PhD (1)  ·  Darren Wilbraham (1)  ·  Jon B Bergmann, Ass. Prof. (1)  ·  Klaus T Olkkola, MD, PhD, Professor (1)  ·  Liyan Miao, PhD (1)  ·  Megan Peters, MD (1)  ·  Sara Abdel Naby, M.D (1)  ·  Stephen Kanes (1)  ·  Timo Iirola (1)  ·  Timo Iirola, MD (1)

Results publications

PMID 21318594, PMID 22030215, PMID 32415708, PMID 41836529